Free Trial
→ The Obscure Korean War Act That Created a $5.39 Billion Passive Income Stream (From Angel Publishing) (Ad)tc pixel Free KNSA Stock Alerts

Kiniksa Pharmaceuticals International (KNSA) SEC Filings & 10K Form

Kiniksa Pharmaceuticals International logo
$36.52 -0.35 (-0.94%)
As of 10:38 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Kiniksa Pharmaceuticals International SEC Filings

Export to Excel
DateFilerForm TypeView
09/08/2025
3:37 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2025
3:38 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025
3:39 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2025
3:51 PM		Kiniksa Pharmaceuticals International (Subject)
Moat Ross (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2025
3:52 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025
4:31 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
3:44 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
3:45 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
3:48 PM		Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
3:49 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
3:56 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
3:16 PM		Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025
6:35 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2025
3:36 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
4:13 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2025
3:36 PM		Kiniksa Pharmaceuticals International (Subject)
Malley Thomas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2025
3:24 PM		Kiniksa Pharmaceuticals International (Subject)
Malley Thomas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025
3:54 PM		Kiniksa Pharmaceuticals International (Subject)
Malley Thomas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2025
3:35 PM		Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
4:37 PM		Kiniksa Pharmaceuticals International (Subject)
Paolini John F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2025
3:30 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
3:30 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
4:23 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2025
3:16 PM		Kiniksa Pharmaceuticals International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2025
6:30 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
6:44 PM		BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
Form SCHEDULE 13G/A
07/16/2025
3:30 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
4:04 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025
3:39 PM		Kiniksa Pharmaceuticals International (Issuer)
Levy Richard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:39 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
4:23 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
4:32 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:35 PM		Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
3:39 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2025
4:46 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2025
3:50 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:53 PM		Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:55 PM		Kiniksa Pharmaceuticals International (Issuer)
Popovits Kimberly J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:59 PM		Kiniksa Pharmaceuticals International (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
4:02 PM		Kiniksa Pharmaceuticals International (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
6:10 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
3:30 PM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
4:25 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
4:23 PM		Kiniksa Pharmaceuticals International (Filer)
Form DEFA14A
05/22/2025
3:38 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
3:37 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:16 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
3:39 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:32 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2025
4:13 PM		Kiniksa Pharmaceuticals International (Subject)
Patel Sanj K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
3:47 PM		Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:49 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:50 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:52 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:53 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:54 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:26 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:24 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
4:10 PM		Kiniksa Pharmaceuticals International (Subject)
Moat Ross (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
4:11 PM		Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2025
3:15 PM		Kiniksa Pharmaceuticals International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2025
6:40 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
6:47 PM		BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:31 PM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:44 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:30 PM		Kiniksa Pharmaceuticals International (Filer)
Form DEFA14A
04/16/2025
3:38 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
3:39 PM		Kiniksa Pharmaceuticals International (Filer)
Form PRE 14A
04/09/2025
3:41 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:42 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:43 PM		Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:44 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:45 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:45 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
5:57 PM		Kiniksa Pharmaceuticals International (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
04/03/2025
4:06 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:52 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:35 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:48 PM		Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:49 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:50 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:51 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:52 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:53 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:29 PM		Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:37 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:38 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:47 PM		Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
3:37 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:13 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
3:31 PM		Kiniksa Pharmaceuticals International (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
3:15 PM		Kiniksa Pharmaceuticals International (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
6:31 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
2:45 PM		Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals International (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:37 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:42 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:27 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:34 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:45 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:17 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:KNSA) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners
Wall Street Legend Issues Urgent AI Stock Warning
Chaikin's stepping forward with a new warning – focused on the red-hot A.I. frenzy taking the U.S. stock marke...
Chaikin Analytics | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
Trump’s Plan May Undo 1933’s Biggest Financial Injustice
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...
American Hartford Gold | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...
Brownstone Research | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel